Riskpilot← Back to searchSign inGet full accessLopeta AB
ABActiveOrg 5568935232Lützengatan 3Medical specialists activities · NACE 8622Est. 20121 employees
Revenue 2025
SEK 1,8M
+469% vs 2024
EBITDA margin
85.6%
+760% vs 2024
Equity ratio
69.9%
Financial strength
Net profit 2025
SEK 1,2M
+651% vs 2024
| Revenue | SEK 1,8M | +469% |
| EBITDA | SEK 1,5M | +760% |
| Net profit | SEK 1,2M | +651% |
| Total assets | SEK 2,7M | +216% |
| Equity | SEK 1,9M | +184% |
| Employees | 1 | — |
Legal name
Lopeta AB
Org number
5568935232
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
16 maj 2012
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget skall bedriva hälso- och sjukvård, import, export och handel med livsmedel, antikviteter, konst och medicinska artiklar. Bedriva medicinsk forskning och utbildning och konsultation. Handel med värdepapper, äga och förvalta aktier andelar och andra värdepapper. Handel med och äga fast egendom samt idka annan därmed förenlig verksamhet.
Address
Lützengatan 3
Email
markus.takanen@yahoo.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 202 | 62 | 62 | 315 | 1 795 |
| Staff expenses | — | — | — | −9 | −45 |
| EBITDA | 84 | −28 | −65 | 179 | 1 536 |
| Depreciation & amort. | −0 | −0 | −0 | — | — |
| EBIT | 84 | −28 | −65 | 179 | 1 536 |
| Net financials | −1 | — | 1 | 2 | 1 |
| Profit before tax | 83 | −28 | −64 | 180 | 1 537 |
| Tax | −18 | −0 | −0 | −18 | −318 |
| Net profit | 65 | −28 | −64 | 162 | 1 219 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 715 | 667 | 627 | 852 | 2 694 |
| Equity | 593 | 565 | 501 | 663 | 1 882 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 122 | 102 | 126 | 188 | 812 |
| Total debt | 122 | 102 | 126 | 188 | 812 |
EBITDA margin
85.6%
This company
15.8%
Market median
+442% vs market
20212025
Equity ratio
69.9%
This company
38.2%
Market median
+83% vs market
20212025
Return on equity
64.8%
This company
18.4%
Market median
+252% vs market
20212025
Net profit margin
67.9%
This company
8.1%
Market median
+738% vs market
20212025
Asset turnover
0.67×
This company
1.12×
Market median
-40% vs market
20212025
Debt / equity
0.43×
This company
0.62×
Market median
+31% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2026 | |
| Former (2) | ||
| Deputy Board Member | 2022 – 2026 | |
| Deputy Board Member | 2022 – 2026 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Lopeta AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Markus Ulf Vilhelm Takanen | Board of Directors | 0 companies |
| Heikki Juhani Takanen | Deputy Board Member | 0 companies |
| Andreas Nils Folke Takanen | Deputy Board Member | 0 companies |
| Natalia Kuchartjuk | Deputy Board Member | 0 companies |